Search results
AstraZeneca to pay $425 million to end US lawsuits over heartburn drugs
Reuters via Yahoo Finance· 8 months ago(Reuters) -Britain's AstraZeneca has agreed to pay $425 million to settle about 11,000 lawsuits in...
AstraZeneca (AZN) Settles Heartburn Drugs Lawsuits for $425M
Zacks via Yahoo Finance· 8 months agoAstraZeneca AZN announced that it has entered into settlement agreements for pending litigations...
AstraZeneca stays in GLP-1 drug race with new deal
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: AstraZeneca is recommitting to the GLP-1 drug development race, announcing Thursday a bet on an experimental therapy from China-based biotech...
AstraZeneca (AZN) Beats on Q2 Earnings, Ups Sales Growth View
Zacks via Yahoo Finance· 2 years agoAstraZeneca's (AZN) second-quarter results reflect a beat on both counts (revenues and earnings)....
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 1 month agoThe Covid-19 vaccine developed by Oxford scientists during the pandemic has been withdrawn from the market. Pharmaceutical giant AstraZeneca said that it...
AstraZeneca (AZN) to Acquire Vaccine Maker Icosavax for $1.1B
Zacks via Yahoo Finance· 6 months agoAstraZeneca AZN announced that it has entered into a definitive agreement to acquire Icosavax, Inc....
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 1 month agoAstraZeneca is withdrawing its COVID vaccine, the company has announced. (PA) Jakub Porzycki,...
Factbox-Vaccines delivered under COVAX sharing scheme for poorer countries
Reuters via Yahoo News· 2 years ago(Reuters) - The COVAX facility, backed by the World Health Organization (WHO) and the Global...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 1 month agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
AstraZeneca (AZN) Buys Global Rights to Oral Obesity Candidate
Zacks via Yahoo Finance· 7 months agoTo cash in on the rising demand for obesity drugs, AstraZeneca (AZN) in-licenses exclusive rights to...